Skip to main content
Erschienen in: Diseases of the Colon & Rectum 7/2006

01.07.2006

Measuring the Quality of Colorectal Cancer Screening: The Importance of Follow-Up

verfasst von: David A. Etzioni, M.D., Elizabeth M. Yano, Ph.D., Lisa V. Rubenstein, M.D., Martin L. Lee, Ph.D., Clifford Y. Ko, M.D., Robert H. Brook, Ph.D., Patricia H. Parkerton, Ph.D., Steven M. Asch, M.D.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 7/2006

Einloggen, um Zugang zu erhalten

Purpose

As evidence mounts for effectiveness, an increasing proportion of the United States population undergoes colorectal cancer screening. However, relatively little is known about rates of follow-up after abnormal results from initial screening tests. This study examines patterns of colorectal cancer screening and follow-up within the nation's largest integrated health care system: the Veterans Health Administration.

Methods

We obtained information about patients who received colorectal cancer screening in the Veterans Health Administration from an existing quality improvement program and from the Veterans Health Administration's electronic medical record. Linking these data, we analyzed receipt of screening and follow-up testing after a positive fecal occult blood test.

Results

A total of 39,870 patients met criteria for colorectal cancer screening; of these 61 percent were screened. Screening was more likely in patients aged 70 to 80 years than in those younger or older. Female gender (relative risk, 0.92; 95 percent confidence interval, 0.9–0.95), Black race (relative risk, 0.92; 95 percent confidence interval, 0.89–0.96), lower income, and infrequent primary care visits were associated with lower likelihood of screening. Of those patients with a positive fecal occult blood test (n = 313), 59 percent received a follow-up barium enema or colonoscopy. Patient-level factors did not predict receipt of a follow-up test.

Conclusions

The Veterans Health Administration rates for colorectal cancer screening are significantly higher than the national average. However, 41 percent of patients with positive fecal occult blood tests failed to receive follow-up testing. Efforts to measure the quality of colorectal cancer screening programs should focus on the entire diagnostic process.
Literatur
1.
Zurück zum Zitat Hardcastle, JD, Chamberlain, JO, Robinson, MH, et al. 1996Randomised controlled trial of faecal-occult-blood screening for colorectal cancerLancet34814721477PubMedCrossRef Hardcastle, JD, Chamberlain, JO, Robinson, MH,  et al. 1996Randomised controlled trial of faecal-occult-blood screening for colorectal cancerLancet34814721477PubMedCrossRef
2.
Zurück zum Zitat Kronborg, O, Fenger, C, Olsen, J, Jorgensen, OD, Sondergaard, O 1996Randomised study of screening for colorectal cancer with faecal-occult-blood testLancet34814671471PubMedCrossRef Kronborg, O, Fenger, C, Olsen, J, Jorgensen, OD, Sondergaard, O 1996Randomised study of screening for colorectal cancer with faecal-occult-blood testLancet34814671471PubMedCrossRef
3.
Zurück zum Zitat Kewenter, J, Brevinge, H, Engaras, B, Haglind, E, Ahren, C 1994Results of screening, rescreening, and follow-up in aprospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjectsScand J Gastroenterol29468473PubMed Kewenter, J, Brevinge, H, Engaras, B, Haglind, E, Ahren, C 1994Results of screening, rescreening, and follow-up in aprospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjectsScand J Gastroenterol29468473PubMed
4.
Zurück zum Zitat Mandel, JS, Bond, JH, Church, TR, et al. 1993Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control StudyN Engl J Med32813651371PubMedCrossRef Mandel, JS, Bond, JH, Church, TR,  et al. 1993Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control StudyN Engl J Med32813651371PubMedCrossRef
5.
Zurück zum Zitat Kewenter, J, Brevinge, H, Engaras, B, Haglind, E, Ahren, C 1994Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trialDis Colon Rectum37115119PubMedCrossRef Kewenter, J, Brevinge, H, Engaras, B, Haglind, E, Ahren, C 1994Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trialDis Colon Rectum37115119PubMedCrossRef
6.
Zurück zum Zitat Kaye, JA, Shulman, LN 1991Screening program for colorectalcancer: participation and follow upHMO Pract5168170PubMed Kaye, JA, Shulman, LN 1991Screening program for colorectalcancer: participation and follow upHMO Pract5168170PubMed
7.
Zurück zum Zitat Lurie, JD, Welch, HG 1999Diagnostic testing following fecal occult blood screening in the elderlyJ Natl Cancer Inst0016411646CrossRef Lurie, JD, Welch, HG 1999Diagnostic testing following fecal occult blood screening in the elderlyJ Natl Cancer Inst0016411646CrossRef
8.
Zurück zum Zitat Shields, HM, Weiner, MS, Henry, DR, et al. 2001Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult bloodAm J Gastroenterol96196203PubMedCrossRef Shields, HM, Weiner, MS, Henry, DR,  et al. 2001Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult bloodAm J Gastroenterol96196203PubMedCrossRef
9.
Zurück zum Zitat Kizer, KW 1999The “new VA”: a national laboratory for health care quality managementAm J Med Qual14320PubMed Kizer, KW 1999The “new VA”: a national laboratory for health care quality managementAm J Med Qual14320PubMed
10.
Zurück zum Zitat Jha, AK, Perlin, JB, Kizer, KW, Dudley, RA 2003Effect of the transformation of the Veterans Affairs Health Care System on the quality of careN Engl J Med348 221827PubMedCrossRef Jha, AK, Perlin, JB, Kizer, KW, Dudley, RA 2003Effect of the transformation of the Veterans Affairs Health Care System on the quality of careN Engl J Med348 221827PubMedCrossRef
11.
Zurück zum Zitat Administration VH. VISTA Monograph; 2003–2004 Administration VH. VISTA Monograph; 2003–2004
12.
Zurück zum Zitat Kizer, KW, Demakis, JG, Feussner, JR 2000Reinventing VA health care: systematizing quality improvement and quality innovationMed Care38I716PubMedCrossRef Kizer, KW, Demakis, JG, Feussner, JR 2000Reinventing VA health care: systematizing quality improvement and quality innovationMed Care38I716PubMedCrossRef
13.
Zurück zum Zitat Weiner, JP, Starfield, BH, Steinwachs, DM, Mumford, LM 1991Development and application of a population-oriented measure of ambulatory care case-mixMed Care29452472PubMed Weiner, JP, Starfield, BH, Steinwachs, DM, Mumford, LM 1991Development and application of a population-oriented measure of ambulatory care case-mixMed Care29452472PubMed
14.
Zurück zum Zitat Franks, P, Mooney, C, Sorbero, M 2000Physician referral rates: style without much substance?Med Care38836846PubMedCrossRef Franks, P, Mooney, C, Sorbero, M 2000Physician referral rates: style without much substance?Med Care38836846PubMedCrossRef
15.
Zurück zum Zitat Franks, P, Fiscella, K 2002Effect of patient socioeconomic status on physician profiles for prevention, disease management, and diagnostic testing costsMed Care40717724PubMedCrossRef Franks, P, Fiscella, K 2002Effect of patient socioeconomic status on physician profiles for prevention, disease management, and diagnostic testing costsMed Care40717724PubMedCrossRef
16.
Zurück zum Zitat Rosen, AK, Loveland, S, Anderson, JJ, et al. 2001Evaluating diagnosis-based case-mix measures: how well do they apply to the VA population?Med Care39692704PubMedCrossRef Rosen, AK, Loveland, S, Anderson, JJ,  et al. 2001Evaluating diagnosis-based case-mix measures: how well do they apply to the VA population?Med Care39692704PubMedCrossRef
17.
Zurück zum Zitat Zhang, J, Yu, KF 1998What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomesJAMA28016901691PubMedCrossRef Zhang, J, Yu, KF 1998What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomesJAMA28016901691PubMedCrossRef
18.
Zurück zum Zitat Yabroff, KR, Washington, KS, Leader, A, Neilson, E, Mandelblatt, J 2003Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening resultsMed Care Res Rev60294331PubMedCrossRef Yabroff, KR, Washington, KS, Leader, A, Neilson, E, Mandelblatt, J 2003Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening resultsMed Care Res Rev60294331PubMedCrossRef
19.
Zurück zum Zitat Turner, B, Myers, RE, Hyslop, T, et al. 2003Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood testJ Gen Intern Med18357363PubMedCrossRef Turner, B, Myers, RE, Hyslop, T,  et al. 2003Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood testJ Gen Intern Med18357363PubMedCrossRef
20.
Zurück zum Zitat Sharma, VK, Vasudeva, R, Howden, CW 2000Colorectal cancer screening and surveillance practices by primary care physicians: results of a national surveyAm J Gastroenterol9515511556PubMedCrossRef Sharma, VK, Vasudeva, R, Howden, CW 2000Colorectal cancer screening and surveillance practices by primary care physicians: results of a national surveyAm J Gastroenterol9515511556PubMedCrossRef
21.
Zurück zum Zitat McGlynn, EA, Asch, SM, Adams, J, et al. 2003The quality of health care delivered to adults in the United StatesN Engl J Med34826352645PubMedCrossRef McGlynn, EA, Asch, SM, Adams, J,  et al. 2003The quality of health care delivered to adults in the United StatesN Engl J Med34826352645PubMedCrossRef
22.
Zurück zum Zitat Swan, J, Breen, N, Coates, RJ, Rimer, BK, Lee, NC 2003Progress in cancer screening practices in the United States: results from the 2000 National Health Interview SurveyCancer9715281540PubMedCrossRef Swan, J, Breen, N, Coates, RJ, Rimer, BK, Lee, NC 2003Progress in cancer screening practices in the United States: results from the 2000 National Health Interview SurveyCancer9715281540PubMedCrossRef
23.
Zurück zum Zitat Breen, N, Wagener, DK, Brown, ML, Davis, WW, Ballard-Barbash, R 2001Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview SurveysJ Natl Cancer Inst9317041713PubMedCrossRef Breen, N, Wagener, DK, Brown, ML, Davis, WW, Ballard-Barbash, R 2001Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview SurveysJ Natl Cancer Inst9317041713PubMedCrossRef
Metadaten
Titel
Measuring the Quality of Colorectal Cancer Screening: The Importance of Follow-Up
verfasst von
David A. Etzioni, M.D.
Elizabeth M. Yano, Ph.D.
Lisa V. Rubenstein, M.D.
Martin L. Lee, Ph.D.
Clifford Y. Ko, M.D.
Robert H. Brook, Ph.D.
Patricia H. Parkerton, Ph.D.
Steven M. Asch, M.D.
Publikationsdatum
01.07.2006
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 7/2006
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-006-0533-2

Weitere Artikel der Ausgabe 7/2006

Diseases of the Colon & Rectum 7/2006 Zur Ausgabe

Announcements

Announcements

Letters to the Editor

The Authors Reply

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.